Consulta: subjectFacets:"Neoadjuvant therapy"
Registros recuperados: 2
Data/hora: 02/06/2024 05:09:34

Gastrointestinal Stromal Tumors (GISTs): Single Center Experience Observed in a Small Series of Cases
Provedor de dados: 77
Autores: Manterola,Carlos; Otzen,Tamara.
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasms developing in the stomach. Usually detected incidentally, they can be single or multiple. The aim of this study is to report the results of surgery in the treatment of GISTs in terms of postoperative morbidity (POM) and recurrence. Case series. Patients surgically treated by GISTs at the Clínica Mayor of Temuco, Chile, between 2008 and 2015 were included. The preoperative study consisted in general diagnostic tests, endoscopy and abdominal CT-Scan. The outcome variable was POM, measured at 30 days postoperatively. Other variables of interest were: surgical time, hospital stay, mortality and recurrence. Minimum follow-up time was 12 months. Descriptive statistics were used....
Tipo: Journal article
Palavras-chave: Gastrointestinal stromal tumors; Gastrointestinal stromal tumors/surgery; Gastrointestinal stromal tumors/therapy; Neoadjuvant therapy; GISTs.
Ano: 2016
URL: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-95022016000200011

Gene trio signatures as molecular markers to predict response to doxorubicin cyclophosphamide neoadjuvant chemotherapy in breast cancerpatients
Provedor de dados: 56
Autores: Katayama,M.L.H.; Brentani,H.; Abreu,A.P.S.; Barbosa,E.M.; Oliveira,C.T.; Góes,J.C.S.; Brentani,M.M.; Folgueira,M.A.A.K.
In breast cancer patients submitted to neoadjuvant chemotherapy (4 cycles of doxorubicin and cyclophosphamide, AC), expression of groups of three genes (gene trio signatures) could distinguish responsive from non-responsive tumors, as demonstrated by cDNA microarray profiling in a previous study by our group. In the current study, we determined if the expression of the same genes would retain the predictive strength, when analyzed by a more accessible technique (real-time RT-PCR). We evaluated 28 samples already analyzed by cDNA microarray, as a technical validation procedure, and 14 tumors, as an independent biological validation set. All patients received neoadjuvant chemotherapy (4 AC). Among five trio combinations previously identified, defined by nine...
Tipo: Info:eu-repo/semantics/other
Palavras-chave: Breast neoplasms; Discriminant analysis; Doxorubicin; Drug resistance; Neoadjuvant therapy; Reverse transcriptase-polymerase chain reaction.
Ano: 2010
URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2010001200012